S.E.E.D. Planning Group LLC Has $3.01 Million Stock Position in Colgate-Palmolive (NYSE:CL)

S.E.E.D. Planning Group LLC increased its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 268.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,091 shares of the company’s stock after acquiring an additional 23,372 shares during the quarter. S.E.E.D. Planning Group LLC’s holdings in Colgate-Palmolive were worth $3,007,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CL. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the 4th quarter worth about $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $27,000. Vermillion Wealth Management Inc. bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $31,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Finally, Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the subject of a number of analyst reports. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a research note on Wednesday, April 2nd. Barclays cut their target price on Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating on the stock in a research note on Friday, April 11th. Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. Finally, Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $102.12.

Get Our Latest Report on CL

Colgate-Palmolive Stock Up 0.5%

Colgate-Palmolive stock opened at $92.25 on Friday. The company has a 50 day moving average of $91.95 and a 200-day moving average of $91.26. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock has a market capitalization of $74.76 billion, a PE ratio of 26.21, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.86 EPS. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were given a dividend of $0.52 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.25%. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive’s dividend payout ratio is currently 58.76%.

Colgate-Palmolive announced that its Board of Directors has initiated a share buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.